$GILD & Yuhan Announce Collab and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to NASH. $15M upfront to Yuhan and up to $770M in milestones JPM19 httpswww.businesswire.comnewshome20190106005116enGilead

$GILD & Yuhan Announce Collab and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to #NASH. $15M upfront to Yuhan and up to $770M in milestones #JPM19 https://www.businesswire.com/news/home/20190106005116/en/Gilead-

18:39 EST 6 Jan 2019 | Odi Bruckman

$GILD & Yuhan Announce Collab and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to #NASH. $15M upfront to Yuhan and up to $770M in milestones #JPM19 https://www.businesswire.com/news/home/20190106005116/en/Gilead-Sciences-Yuhan-Corporation-Announce-Collaboration-License …

More From BioPortfolio on "$GILD & Yuhan Announce Collab and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to #NASH. $15M upfront to Yuhan and up to $770M in milestones #JPM19 https://www.businesswire.com/news/home/20190106005116/en/Gilead-"